3. GOOD HEALTH AND WELL-BEING

Oscar Health (NYSE:OSCR) PT Raised to $16.00 at The Goldman Sachs Group

Written by Amanda

Oscar Health (NYSE:OSCRGet Free Report) had its target price boosted by The Goldman Sachs Group from $8.00 to $16.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price points to a potential downside of 6.60% from the stock’s previous close.

Separately, Bank of America upgraded Oscar Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $8.00 to $9.00 in a research note on Thursday, November 2nd. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Oscar Health has a consensus rating of “Hold” and a consensus price target of $9.40.

Read Our Latest Report on OSCR

Oscar Health Stock Up 2.7 %

Shares of NYSE:OSCR traded up $0.45 during trading on Friday, reaching $17.13. 1,186,927 shares of the stock were exchanged, compared to its average volume of 3,570,639. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.36 and a quick ratio of 1.36. Oscar Health has a 1-year low of $3.22 and a 1-year high of $17.55. The stock has a fifty day moving average of $10.17 and a two-hundred day moving average of $7.78. The firm has a market cap of $3.87 billion, a price-to-earnings ratio of -14.27 and a beta of 1.72.

Oscar Health (NYSE:OSCRGet Free Report) last released its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.08. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative return on equity of 28.95% and a negative net margin of 4.62%. Oscar Health’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same period in the prior year, the firm posted ($1.05) EPS. Research analysts anticipate that Oscar Health will post -0.05 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, CFO Richard Scott Blackley sold 30,029 shares of the firm’s stock in a transaction dated Wednesday, December 6th. The stock was sold at an average price of $8.16, for a total value of $245,036.64. Following the sale, the chief financial officer now owns 548,613 shares of the company’s stock, valued at approximately $4,476,682.08. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, EVP Alessandrea C. Quane sold 16,793 shares of the firm’s stock in a transaction dated Wednesday, December 6th. The stock was sold at an average price of $8.16, for a total transaction of $137,030.88. Following the transaction, the executive vice president now directly owns 301,223 shares of the company’s stock, valued at approximately $2,457,979.68. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Richard Scott Blackley sold 30,029 shares of the firm’s stock in a transaction dated Wednesday, December 6th. The shares were sold at an average price of $8.16, for a total value of $245,036.64. Following the transaction, the chief financial officer now directly owns 548,613 shares in the company, valued at $4,476,682.08. The disclosure for this sale can be found here. Insiders have sold a total of 437,227 shares of company stock valued at $3,161,751 in the last 90 days. Corporate insiders own 25.54% of the company’s stock.

Institutional Trading of Oscar Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Covestor Ltd lifted its holdings in Oscar Health by 310.0% in the second quarter. Covestor Ltd now owns 3,329 shares of the company’s stock valued at $27,000 after acquiring an additional 2,517 shares during the period. Dark Forest Capital Management LP increased its stake in Oscar Health by 5,243.2% in the 1st quarter. Dark Forest Capital Management LP now owns 7,801 shares of the company’s stock worth $51,000 after acquiring an additional 7,655 shares during the last quarter. Metropolitan Life Insurance Co NY raised its stake in Oscar Health by 63.9% during the second quarter. Metropolitan Life Insurance Co NY now owns 8,520 shares of the company’s stock valued at $69,000 after purchasing an additional 3,323 shares in the last quarter. Advisor Group Holdings Inc. raised its stake in Oscar Health by 157.5% during the first quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company’s stock valued at $101,000 after purchasing an additional 6,182 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in Oscar Health by 959.5% during the third quarter. Royal Bank of Canada now owns 10,129 shares of the company’s stock valued at $50,000 after purchasing an additional 9,173 shares in the last quarter. Institutional investors own 66.70% of the company’s stock.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products.

Featured Articles

Analyst Recommendations for Oscar Health (NYSE:OSCR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Oscar Health, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Oscar Health wasn’t on the list.

While Oscar Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Source: marketbeat.com

Oscar Health (NYSE:OSCRGet Free Report) had its target price boosted by The Goldman Sachs Group from $8.00 to $16.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price points to a potential downside of 6.60% from the stock’s previous close.

Separately, Bank of America upgraded Oscar Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $8.00 to $9.00 in a research note on Thursday, November 2nd. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Oscar Health has a consensus rating of “Hold” and a consensus price target of $9.40.

Read Our Latest Report on OSCR

Oscar Health Stock Up 2.7 %

Shares of NYSE:OSCR traded up $0.45 during trading on Friday, reaching $17.13. 1,186,927 shares of the stock were exchanged, compared to its average volume of 3,570,639. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.36 and a quick ratio of 1.36. Oscar Health has a 1-year low of $3.22 and a 1-year high of $17.55. The stock has a fifty day moving average of $10.17 and a two-hundred day moving average of $7.78. The firm has a market cap of $3.87 billion, a price-to-earnings ratio of -14.27 and a beta of 1.72.

Oscar Health (NYSE:OSCRGet Free Report) last released its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.08. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative return on equity of 28.95% and a negative net margin of 4.62%. Oscar Health’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same period in the prior year, the firm posted ($1.05) EPS. Research analysts anticipate that Oscar Health will post -0.05 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, CFO Richard Scott Blackley sold 30,029 shares of the firm’s stock in a transaction dated Wednesday, December 6th. The stock was sold at an average price of $8.16, for a total value of $245,036.64. Following the sale, the chief financial officer now owns 548,613 shares of the company’s stock, valued at approximately $4,476,682.08. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, EVP Alessandrea C. Quane sold 16,793 shares of the firm’s stock in a transaction dated Wednesday, December 6th. The stock was sold at an average price of $8.16, for a total transaction of $137,030.88. Following the transaction, the executive vice president now directly owns 301,223 shares of the company’s stock, valued at approximately $2,457,979.68. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Richard Scott Blackley sold 30,029 shares of the firm’s stock in a transaction dated Wednesday, December 6th. The shares were sold at an average price of $8.16, for a total value of $245,036.64. Following the transaction, the chief financial officer now directly owns 548,613 shares in the company, valued at $4,476,682.08. The disclosure for this sale can be found here. Insiders have sold a total of 437,227 shares of company stock valued at $3,161,751 in the last 90 days. Corporate insiders own 25.54% of the company’s stock.

Institutional Trading of Oscar Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Covestor Ltd lifted its holdings in Oscar Health by 310.0% in the second quarter. Covestor Ltd now owns 3,329 shares of the company’s stock valued at $27,000 after acquiring an additional 2,517 shares during the period. Dark Forest Capital Management LP increased its stake in Oscar Health by 5,243.2% in the 1st quarter. Dark Forest Capital Management LP now owns 7,801 shares of the company’s stock worth $51,000 after acquiring an additional 7,655 shares during the last quarter. Metropolitan Life Insurance Co NY raised its stake in Oscar Health by 63.9% during the second quarter. Metropolitan Life Insurance Co NY now owns 8,520 shares of the company’s stock valued at $69,000 after purchasing an additional 3,323 shares in the last quarter. Advisor Group Holdings Inc. raised its stake in Oscar Health by 157.5% during the first quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company’s stock valued at $101,000 after purchasing an additional 6,182 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in Oscar Health by 959.5% during the third quarter. Royal Bank of Canada now owns 10,129 shares of the company’s stock valued at $50,000 after purchasing an additional 9,173 shares in the last quarter. Institutional investors own 66.70% of the company’s stock.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products.

Featured Articles

Analyst Recommendations for Oscar Health (NYSE:OSCR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Oscar Health, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Oscar Health wasn’t on the list.

While Oscar Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Source: marketbeat.com

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai

Leave a Comment